Well done NEU. This is a great milestone as patient recruitment is (way) more than half the battle.
Not a holder but quietly watching from the side.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren completes enrolment in INTREPID clinical trial
Ann: Neuren completes enrolment in INTREPID clinical trial, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.25 |
Change
-0.255(1.31%) |
Mkt cap ! $2.468B |
Open | High | Low | Value | Volume |
$19.50 | $19.59 | $19.11 | $3.658M | 188.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 49 | $19.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.25 | 209 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 49 | 19.230 |
11 | 506 | 19.220 |
5 | 350 | 19.210 |
8 | 1853 | 19.200 |
5 | 382 | 19.190 |
Price($) | Vol. | No. |
---|---|---|
19.250 | 241 | 6 |
19.260 | 321 | 8 |
19.270 | 411 | 6 |
19.280 | 298 | 5 |
19.290 | 231 | 3 |
Last trade - 14.58pm 10/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online